Mytrah Energy India Ltd has raised R100Cr – mezzanine funding from @PTC_India_Fi Ltd.
This was the third tranche of funding received by the Mytrah as part of a total mezzanine funding to $132 million.
There would be no equity dilution for Mytrah Energy's existing shareholders from the funding. The Group expects to repurchase all tranches of mezzanine funding from internal cash flows and the issue of senior debt instruments, bonds or other debt refinancing, within three to five years.
Along with the merger of Shasun Pharmaceutical with itself, Strides Arcolab also announced the induction of a strategic partner in its greenfield biotech project, Stelis Biopharma. As per the deal GMS Holding will pick up 25.1%s stake in the biotech arm infusing $8.5Mn.
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.